ImmunoPrecise Antibodies Ltd. (CVE:IPA – Get Free Report)’s share price shot up 0.8% on Monday . The company traded as high as C$6.70 and last traded at C$6.50. 19,980 shares traded hands during trading, an increase of 3% from the average session volume of 19,376 shares. The stock had previously closed at C$6.45.
ImmunoPrecise Antibodies Stock Performance
The company has a debt-to-equity ratio of 1.70, a quick ratio of 4.29 and a current ratio of 5.06. The company has a market cap of C$162.08 million and a PE ratio of -7.30. The company’s 50 day moving average price is C$6.50 and its 200-day moving average price is C$6.50.
About ImmunoPrecise Antibodies
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes.
Further Reading
- Five stocks we like better than ImmunoPrecise Antibodies
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- What Are Treasury Bonds?
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
